GSK-Pfizer deal gets approval from Australia's anti-trust watchdog

इंडिया समाचार समाचार

GSK-Pfizer deal gets approval from Australia's anti-trust watchdog
इंडिया ताज़ा खबर,इंडिया मुख्य बातें
  • 📰 Reuters
  • ⏱ Reading Time:
  • 9 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 97%

GlaxoSmithKline's deal to buy Pfizer's consumer healthcare business wi...

FILE PHOTO: The GlaxoSmithKline logo is seen on top of GSK Asia House in Singapore, March 21, 2018. REUTERS/Loriene Perera/File Photo

The two pharmaceutical giants in December said they would combine their consumer health businesses in a joint venture that would be 68 percent-owned by GSK.

हमने इस समाचार को संक्षेप में प्रस्तुत किया है ताकि आप इसे तुरंत पढ़ सकें। यदि आप समाचार में रुचि रखते हैं, तो आप पूरा पाठ यहां पढ़ सकते हैं। और पढो:

Reuters /  🏆 2. in US

इंडिया ताज़ा खबर, इंडिया मुख्य बातें

Similar News:आप इससे मिलती-जुलती खबरें भी पढ़ सकते हैं जिन्हें हमने अन्य समाचार स्रोतों से एकत्र किया है।

Pfizer And Others Join Working Group To Use Blockchain Protocol For Supply Chain ManagementPfizer And Others Join Working Group To Use Blockchain Protocol For Supply Chain ManagementPfizer Inc., McKesson Corporation, AmerisourceBergen Corporation, and Premier Inc. have all joined the MediLedger Project Contracting and Chargebacks working group that is using blockchain technology to dramatically improve the complex process of chargebacks.
और पढो »

Pfizer And Others Join Working Group To Use Blockchain Protocol For Supply Chain ManagementPfizer And Others Join Working Group To Use Blockchain Protocol For Supply Chain ManagementPfizer Inc., McKesson Corporation, AmerisourceBergen Corporation, and Premier Inc. have all joined the MediLedger Project Contracting and Chargebacks working group that is using blockchain technology to dramatically improve the complex process of chargebacks.
और पढो »

Pfizer gets U.S. approval for $225,000 a year heart drugPfizer gets U.S. approval for $225,000 a year heart drugThe U.S. Food and Drug Administration on Monday approved Pfizer Inc's oral ...
और पढो »

Insurers Brace For Pfizer's $225K Heart Drug And Whether To Pay For ItInsurers Brace For Pfizer's $225K Heart Drug And Whether To Pay For ItPfizer won U.S. approval for its drug tafamidis to treat a rare heart disease, but whether the treatment that costs $225,000 year will be covered by heath insurers and employers remains unclear
और पढो »

Pfizer gets U.S. approval for $225,000 a year heart drugPfizer gets U.S. approval for $225,000 a year heart drugThe U.S. Food and Drug Administration on Monday approved Pfizer Inc's oral ...
और पढो »

Sanofi’s Dengue Vaccine Gets FDA ApprovalSanofi’s Dengue Vaccine Gets FDA ApprovalSanofi dengue vaccine was approved in the U.S., the first treatment cleared by American regulators to protect against the mosquito-borne viral infection.
और पढो »

A Formerly Anti-Vax Mom Posted Why Her Kids Are Getting VaccinatedA Formerly Anti-Vax Mom Posted Why Her Kids Are Getting VaccinatedA Mom Who Grew Up Unvaccinated Said She's Now 'Proud To Vaccinate' Her Own Kids
और पढो »

Pfizer And Others Join Working Group To Use Blockchain Protocol For Supply Chain ManagementPfizer And Others Join Working Group To Use Blockchain Protocol For Supply Chain ManagementPfizer Inc., McKesson Corporation, AmerisourceBergen Corporation, and Premier Inc. have all joined the MediLedger Project Contracting and Chargebacks working group that is using blockchain technology to dramatically improve the complex process of chargebacks.
और पढो »

Pfizer And Others Join Working Group To Use Blockchain Protocol For Supply Chain ManagementPfizer And Others Join Working Group To Use Blockchain Protocol For Supply Chain ManagementPfizer Inc., McKesson Corporation, AmerisourceBergen Corporation, and Premier Inc. have all joined the MediLedger Project Contracting and Chargebacks working group that is using blockchain technology to dramatically improve the complex process of chargebacks.
और पढो »

Insurers Brace For Pfizer's $225K Heart Drug And Whether To Pay For ItInsurers Brace For Pfizer's $225K Heart Drug And Whether To Pay For ItPfizer won U.S. approval for its drug tafamidis to treat a rare heart disease, but whether the treatment that costs $225,000 year will be covered by heath insurers and employers remains unclear
और पढो »

CNN Poll: Trump's approval rating on the economy hits a new highCNN Poll: Trump's approval rating on the economy hits a new highPresident Donald Trump hits a new high on his economic approval ratings in a new CNN Poll conducted by SSRS, reaching 56% of Americans saying he's doing a good job on the economy.
और पढो »



Render Time: 2025-02-27 04:59:18